Cognition Therapeutics Stock Price History

Stocks . USA . 
Stock . Cognition Therapeutics
CGTX Stock  USD 0.72  0.05  6.49%   
If you're considering investing in Cognition Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cognition Therapeutics stands at 0.72, as last reported on the 1st of February, with the highest price reaching 0.79 and the lowest price hitting 0.71 during the day. Cognition Therapeutics appears to be out of control, given 3 months investment horizon. Cognition Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. By analyzing Cognition Therapeutics' technical indicators, you can evaluate if the expected return of 0.94% is justified by implied risk. Please makes use of Cognition Therapeutics' Downside Deviation of 5.8, risk adjusted performance of 0.0812, and Mean Deviation of 5.26 to double-check if our risk estimates are consistent with your expectations.
  
At this time, Cognition Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 200.2 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 27.5 M in 2025. . At this time, Cognition Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.0006 in 2025, despite the fact that Price Earnings Ratio is likely to grow to (1.84). Cognition Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1301

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCGTX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.26
  actual daily
64
64% of assets are less volatile

Expected Return

 0.94
  actual daily
18
82% of assets have higher returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average Cognition Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cognition Therapeutics by adding it to a well-diversified portfolio.
Price Book
2.0742
Book Value
0.761
Enterprise Value
8.6 M
Enterprise Value Ebitda
(0.44)
Shares Float
33.9 M

Cognition Therapeutics Stock Price History Chart

There are several ways to analyze Cognition Stock price data. The simplest method is using a basic Cognition candlestick price chart, which shows Cognition Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 6, 20250.85
Lowest PriceDecember 4, 20240.38

Cognition Therapeutics February 1, 2025 Stock Price Synopsis

Various analyses of Cognition Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cognition Stock. It can be used to describe the percentage change in the price of Cognition Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cognition Stock.
Cognition Therapeutics Price Daily Balance Of Power(0.62)
Cognition Therapeutics Price Action Indicator(0.06)
Cognition Therapeutics Price Rate Of Daily Change 0.94 

Cognition Therapeutics February 1, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Cognition Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Cognition Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Cognition Stock and then apply it to test your longer-term investment strategies against Cognition.

Cognition Stock Price History Data

The price series of Cognition Therapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 0.47 with a coefficient of variation of 24.72. The prices are distributed with arithmetic mean of 0.58. The median price for the last 90 days is 0.54.
OpenHighLowCloseVolume
02/01/2025
 0.79  0.79  0.71  0.72 
01/31/2025 0.79  0.79  0.71  0.72  1,386,295 
01/30/2025 0.78  0.82  0.71  0.77  2,464,448 
01/29/2025 0.76  0.79  0.72  0.76  666,287 
01/28/2025 0.73  0.76  0.72  0.76  681,313 
01/27/2025 0.75  0.77  0.70  0.71  732,301 
01/24/2025 0.80  0.80  0.75  0.75  752,870 
01/23/2025 0.78  0.81  0.74  0.79  843,598 
01/22/2025 0.74  0.78  0.74  0.77  929,339 
01/21/2025 0.69  0.75  0.69  0.74  558,142 
01/17/2025 0.67  0.70  0.66  0.68  655,131 
01/16/2025 0.71  0.71  0.68  0.69  461,477 
01/15/2025 0.73  0.75  0.69  0.71  673,561 
01/14/2025 0.76  0.76  0.71  0.71  827,382 
01/13/2025 0.73  0.76  0.67  0.74  1,305,983 
01/10/2025 0.76  0.79  0.75  0.76  856,004 
01/08/2025 0.82  0.82  0.73  0.79  1,392,947 
01/07/2025 0.82  0.87  0.78  0.82  2,600,865 
01/06/2025 0.78  0.90  0.76  0.85  4,108,917 
01/03/2025 0.72  0.78  0.70  0.76  2,767,308 
01/02/2025 0.71  0.77  0.67  0.72  2,114,926 
12/31/2024 0.73  0.76  0.69  0.70  2,200,115 
12/30/2024 0.81  0.82  0.69  0.75  4,765,543 
12/27/2024 0.77  0.88  0.73  0.84  8,475,473 
12/26/2024 0.65  0.79  0.65  0.77  7,890,280 
12/24/2024 0.61  0.68  0.60  0.65  2,849,568 
12/23/2024 0.63  0.63  0.57  0.61  4,028,288 
12/20/2024 0.64  0.68  0.58  0.63  7,802,415 
12/19/2024 0.65  0.68  0.57  0.63  32,352,811 
12/18/2024 1.15  1.29  0.55  0.58  289,407,406 
12/17/2024 0.45  0.46  0.43  0.45  700,312 
12/16/2024 0.48  0.48  0.44  0.45  723,686 
12/13/2024 0.50  0.51  0.46  0.48  860,934 
12/12/2024 0.49  0.52  0.47  0.51  1,603,029 
12/11/2024 0.44  0.52  0.40  0.49  2,653,368 
12/10/2024 0.46  0.46  0.43  0.43  641,171 
12/09/2024 0.42  0.47  0.42  0.46  1,375,294 
12/06/2024 0.39  0.43  0.38  0.42  1,292,541 
12/05/2024 0.38  0.39  0.38  0.38  885,294 
12/04/2024 0.39  0.39  0.38  0.38  906,740 
12/03/2024 0.41  0.41  0.38  0.39  1,012,712 
12/02/2024 0.41  0.41  0.39  0.40  1,473,640 
11/29/2024 0.40  0.40  0.38  0.40  866,243 
11/27/2024 0.41  0.41  0.38  0.40  1,896,882 
11/26/2024 0.39  0.41  0.38  0.40  7,019,654 
11/25/2024 0.48  0.48  0.38  0.41  47,272,113 
11/22/2024 0.44  0.45  0.41  0.43  263,943 
11/21/2024 0.44  0.45  0.43  0.44  513,574 
11/20/2024 0.44  0.47  0.43  0.44  861,181 
11/19/2024 0.45  0.46  0.43  0.44  292,481 
11/18/2024 0.48  0.49  0.46  0.46  205,860 
11/15/2024 0.50  0.51  0.46  0.46  336,050 
11/14/2024 0.53  0.54  0.50  0.51  248,605 
11/13/2024 0.60  0.60  0.53  0.54  340,120 
11/12/2024 0.51  0.62  0.50  0.60  815,318 
11/11/2024 0.51  0.52  0.48  0.51  300,953 
11/08/2024 0.50  0.52  0.50  0.51  268,463 
11/07/2024 0.52  0.53  0.51  0.52  335,371 
11/06/2024 0.52  0.52  0.49  0.50  298,927 
11/05/2024 0.47  0.51  0.47  0.49  352,284 
11/04/2024 0.47  0.49  0.44  0.47  469,725 

About Cognition Therapeutics Stock history

Cognition Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cognition is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cognition Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cognition Therapeutics stock prices may prove useful in developing a viable investing in Cognition Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding34.5 M27.5 M
Net Loss-19.3 M-20.2 M

Cognition Therapeutics Quarterly Net Working Capital

14.12 Million

Cognition Therapeutics Stock Technical Analysis

Cognition Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Overlap Analysis
View
Forecast Models
View
Price Shifting
View
Volatility Indicators
View
Value Movement
View
A focus of Cognition Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cognition Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Cognition Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cognition Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cognition Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cognition to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance0.0812
Jensen Alpha0.5458
Total Risk Alpha0.022
Sortino Ratio0.0943
Treynor Ratio0.6063
Cycle Indicators
Math Operators
Math Transform
Momentum Indicators
Overlap Studies
Pattern Recognition
Price Transform
Statistic Functions
Volatility Indicators
Volume Indicators

Additional Tools for Cognition Stock Analysis

When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY